8Lasota J, Miettinen M. Clinical significance of oncogenic C-kit and PDGFR-a mutations in gastrointestinal stromal tumors [J]. Histopathology, 2008, 53: 245-266.
9Hou YY, GrabeUus F, Weber F, et al. Impact of C-kit and PDGFR-a gene mutations on prognosis of patients with gastrointestinal stromal tumors after complete primary tumor resection [J]. J Gastrointest Surg, 2009, 13: 1583-1592.
10Licgl B, Hornick YL,Corlcss CL,et al.Monoclonal antibody DOGI. I shows higher sensitivity than C-kit in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes[J]. Am J Surg Pathol, 2009, 33: 437-446.
7Tateishi U, Hasegawa T, Satake M, et al.Gastrointestinal stromal tumor: correlation of computed tomography findings with tumor grade and mortality [J] . Comput Assist Tomogr,2003,(27): 792-798.
8Kima HC, Leea JM, Kima KW, et al. Gastrointestinal stromal tumors of the stomach: CT findings and prediction of malignancy [J]. AJR, 2004, 183 (4): 893 - 898.
9Horton KM, Fishman EK. Current role of CT in imaging of the stomach [J].Radio Graphics, 2003,(23):75-87.
10LuxML, Rubin BP,Biase TL, et al. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors [J]. Am J Pathol, 2000, 156 (3): 791-795.
